Articles From: Global Eagle Entertainment Partners With OnAir to Launch WISE(TM), Its Wireless Inflight Entertainment Solution, on Philippine Airlines to SolarCity Appoints Semiconductor Veteran Brad Buss as Chief Financial Officer


HILLSBORO, Ore., Aug.
Sign-up for FEI Reports New Advances in Neuroscience in Collaboration With NIH investment picks
- Amended Design Expedites Phase 1/2 Trial of Heat's Immuno-Therapy Bladder Cancer Product Candidate – - Provides Accelerated Timeline to Phase 2 Results - DURHAM, N.C., Aug.
Sign-up for Heat Biologics Amends Bladder Cancer Protocol for Early Advancement Into Phase 2 Clinical Studies investment picks
KIRKLAND, Wash., Aug.
Sign-up for Rightside Group Announces Board of Directors and Executive Team investment picks
CLEARWATER, Fla., Aug.
Sign-up for Tech Data Mobile Solutions Boosts CellManage Platform for Partners investment picks
COSTA MESA, Calif., Aug.
Sign-up for Ross Macdonald Named SVP & Regional Manager of Pacific Mercantile Bank's San Juan Capistrano Office investment picks
NORCROSS, Ga., Aug.
Sign-up for Galectin Therapeutics Responds to Class Action Lawsuit investment picks
JACKSONVILLE, Fla., Aug.
Sign-up for ParkerVision to Host Second Quarter 2014 Conference Call and Webcast on August 11 at 4:30 PM ET investment picks
SHREWSBURY, N.J., Aug.
Sign-up for InterCloud Secures New Professional Services Project investment picks
MINNEAPOLIS, Aug.
Sign-up for SPS Commerce to Present at Upcoming Financial Conferences investment picks
JERSEY, Channel Islands, Aug.
Sign-up for Quotient Appoints Sarah O'Connor to Board of Directors investment picks
CGI's proprietary genomic test has been CLIA and NYS licensed to stratify CLL and SLL patient into three distinct outcome groups: favorable, intermediate, and unfavorable It is the only comprehensive test to report on 20 clinically-validated and disease-relevant genomic regions focused on CLL and SLL The proprietary genomic test addresses a growing market of over 120,000 patients for the most common form of leukemia (CLL/SLL) RUTHERFORD, N.J., Aug.
Sign-up for Cancer Genetics, Inc. Releases the Only Comprehensive Genomic Test to Diagnose & Stratify the Most Common Form of Leukemia (CLL) investment picks
BRENTWOOD, Tenn., Aug.
Sign-up for Diversicare Announces the Acquisition of Operations of Two Facilities in Ohio investment picks
BURLINGTON, Mass., Aug.
Sign-up for Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results investment picks
Second Quarter Highlights: Revenue of $101.3 million, up 2.3% year-over-year Loss from continuing operations of $(2.6) million; as adjusted income from continuing operations of $6.4 million Loss per share from continuing operations of $(0.07); as adjusted earnings per share from continuing operations of $0.17 Debt leverage at 3.01 times as adjusted LTM EBITDA WARSAW, Ind., Aug.
Sign-up for Symmetry Medical Reports Second Quarter 2014 Financial Results investment picks
MCLEAN, Va., Aug.
Sign-up for First Satellite Engineering Model Complete for Iridium NEXT investment picks
2014/8/4
BOCA RATON, Fla., Aug.
Sign-up for Celsius(R) Launches Fitness Challenge With TriStar Motorsports and NASCAR Driver Blake Koch investment picks
SAN MATEO, Calif., Aug.
Sign-up for SolarCity Appoints Semiconductor Veteran Brad Buss as Chief Financial Officer investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Global Eagle Entertainment Partners With OnAir to Launch WISE(TM), Its Wireless Inflight Entertainment Solution, on Philippine Airlines to SolarCity Appoints Semiconductor Veteran Brad Buss as Chief Financial Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent